METHYLPHENIDATE AND COGNITIVE THERAPY WITH ADD CHILDREN - A METHODOLOGICAL RECONSIDERATION
METHYLPHENIDATE AND COGNITIVE THERAPY WITH ADD CHILDREN - A METHODOLOGICAL RECONSIDERATION
复制标题
DOI：
10.1007/bf01260518
复制
发表时间：
1986-12-01
影响因子：
3.6
通讯作者：
CLINGERMAN, SR
中科院分区：
文献类型：
--
作者：
BROWN, RT;BORDEN, KA;CLINGERMAN, SR
这项双盲研究考察了哌醋甲酯、认知疗法以及它们的组合对注意缺陷障碍(ADD)儿童的影响。比较四个治疗组在注意力部署和认知风格、学业成绩测试和行为评定量表方面的差异。与该实验室之前进行的一项研究相反，这项研究中的儿童在后测试期间没有接受药物治疗。结果被解释为表明，一旦停止药物治疗，刺激性药物的可测量效果就会迅速消失。研究发现，哌醋甲酯和认知疗法的结合并不比单独研究的任何一种疗法更有效。讨论表明，随访时的用药状况是研究设计的一个基本特征。
The present double-blind study examined the effects of methylphenidate, cognitive therapy, and their combination in attention deficit-disordered (ADD) children. Four treatment groups were compared on measures of attentional deployment and cognitive style, tests of academic achievement, and behavioral rating scales. In contrast to a previous study conducted in this laboratory, children in this study were not receiving medication during post-testing. Results were interpreted to suggest that measurable effects of stimulant medication dissipate rapidly upon discontinuation of pharmacotherapy. The combination of methylphenidate and cognitive therapy was not found to be any more efficacious than either of the treatments studied alone. Discussion suggests that medication status at follow-up is an essential feature of research design.